Fri, 19th Oct 2018 13:10
IP Group plots maiden buyback as makes "strong headway" in first half
Read more(Sharecast News) - Intellectual property-based business developer IP Group said on Thursday that it will launch a £20.0m share buyback after witnessing a rise in interim profits.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIP Group's Artios raises USD153 million for cancer therapy pipeline
Read more(Sharecast News) - Intellectual property-based business investor IP Group said on Tuesday that portfolio company Artios Pharma had completed a $153.0m Series C financing to fund the further development of its clinical-stage pipeline.
Read moreIN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares
Read moreIP Group investee Apollo Therapeutics completes USD145 million raise
Read more(Sharecast News) - Intellectual property business IP Group said on Thursday that portfolio company Apollo Therapeutics had completed a $145.0m financing round.
Read moreIN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise
Read moreIN BRIEF: IP Group expects GBP80 million in first half realisations
Read more(Sharecast News) - Intellectual property business developer IP Group said on Wednesday that for the year to date, its positive progress made by many of its portfolio companies in 2020 had continued.
Read moreIP Group sells part of Iksuda Therapeutics stake in financing round
Read more(Sharecast News) - Intellectual property business developer IP Group said its portfolio company Iksuda Therapeutics had completed a $42m (£29m) financing round to fund human clinical trials of its lead cancer drug.
Read more